International Joint Center for Biomedical Innovation (JCBI)     International Joint Center for Biomedical Innovation (JCBI)
Position: JCBI HOME/Our Research/Diseases Detection
Diseases Detection

We aim to transform the way that we can currently detect disease at early stage through innovations in the design and development of nanomaterials-based biosensors that could be used to precisely detect a number of diseases with global implications, such as cancer (a third of the population) and neurodegenerative diseases (1.8 million deaths/year). Each disease state introduces biomolecular changes in signatures of proteins, enzymes or nucleic acid make-ups that represent targets for diagnostic tests. If detected and quantified accurately, these molecular changes can be read as a ‘signature’ of a particular disease state, yet currently used tests suffer from inaccuracy, insensitivity, difficulties with implementation or high costs. This program is developing new low-cost approaches that can look at larger profiles of subtle molecular changes, are much more sensitive to particular disease states and are designed to be transformative for the biosensing field.

 International Joint Center
for Biomedical Innovation (JCBI)
School of Life Sciences, Henan University, Jin Ming Avenue, Kaifeng, Henan, 475004, China